MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
MeiraGTx Holdings plcNASDAQ: MGTX
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue dips below year-ago levels
Q1 FY2026 revenue of $293K fell 84.8% year over year, behind the +131.1% change in trailing-twelve-month revenue. Sequentially, it fell 99.6% from the prior quarter. Over 3 fiscal years it compounded at +72.3% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $333.88M (+310.2%) for the fiscal year ending Dec 2026, a step up from the +144.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $293K-99.6% QoQ
- Last fiscal yearDec 2025
- $81.39M+144.6% YoY
- LTMMar 2026
- $79.76M+131.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -84.8% | -81.0% | +3.8 pp |
| 1 year | +144.6% | +310.2% | +165.6 pp |
| 3-year CAGR | +72.3% | +24.0% | -48.3 pp |
| 5-year CAGR | +48.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 81.39M USD
- Year-over-year change
- +144.6%
- 4-year CAGR
- +21.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.39M | +144.6% |
| FY2024 | 2024-12-31 | 33.28M | +137.4% |
| FY2023 | 2023-12-31 | 14.02M | -12.0% |
| FY2022 | 2022-12-31 | 15.92M | -57.8% |
| FY2021 | 2021-12-31 | 37.7M | — |
Revenue vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's LTM Mar 2026 revenue of $79.76M is the 4th highest of the 9 companies compared; the peer median is $42.09M.
- Its year-over-year change of +131.1% is the 2nd highest of 8, against a peer median of +22.6%.
- Over three fiscal years its annual growth of +72.3% compares with a peer median of +11.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $440.48M | +22.6% | — | |
| LTM Mar 2026 | $88.24M | +383560.9% | +200.9% | |
| LTM Mar 2026 | $87.82M | -44.0% | +14.8% | |
| LTM Mar 2026 | $79.76M | +131.1% | +72.3% | |
| LTM Mar 2026 | $66.09M | +45.0% | +9.1% | |
| LTM Mar 2026 | $18.09M | -10.4% | -46.7% | |
| LTM Mar 2026 | $14.78M | +54.6% | -0.3% | |
| LTM Mar 2026 | $4.47M | -1.3% | +21.0% | |
| LTM Mar 2026 | $0 | — | — | |
| Peer median (excluding MGTX) | $42.09M | +22.6% | +11.9% | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.7M | 15.92M | 14.02M | 33.28M | 81.39M |
| Cost of Revenue | 0 | 0 | 0 | 23.79M | 4.84M |
| Gross Profit | 37.7M | 15.92M | 14.02M | 9.49M | 76.55M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 28.5% | 94.0% |
| Research & Development | 66.69M | 85.73M | 103.79M | 119.48M | 129.62M |
| Selling, General & Admin | 43.77M | 46.55M | 47.29M | 54.22M | 52.9M |
| Operating Expenses | 110.46M | 132.28M | 151.08M | 173.7M | 182.52M |
| Depreciation & Amortization | 7.87M | 8.6M | 13.73M | 12.83M | 12.61M |
| EBITDA | (71.4M) | (116.07M) | (57.05M) | (121.69M) | (89.4M) |
| EBITDA Margin | -189.4% | -729.1% | -407.0% | -365.7% | -109.8% |
| Operating Income | (72.76M) | (116.36M) | (137.06M) | (164.21M) | (105.97M) |
| Operating Margin | -193.0% | -730.9% | -977.8% | -493.4% | -130.2% |
| Interest Income | 212K | 777K | 2.27M | 4.15M | 1.82M |
| Interest Expense | 288K | 4.95M | 13.25M | 13.27M | 12.2M |
| Other Income / Expenses | (6.8M) | (13.26M) | 53.03M | 16.42M | (8.23M) |
| Income Before Tax | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Pre-Tax Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Net Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| EPS (Basic) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| EPS (Diluted) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| Weighted Avg Shares | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
| Weighted Avg Shares (Diluted) | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.